Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cold Atmospheric Pressure Plasma Jet for the Treatment of Aspergillus Keratitis Publisher



Nikmaram H1 ; Rezaei Kanavi M2 ; Ghoranneviss M1 ; Balagholi S2, 3 ; Ahmadieh H4 ; Roshandel D2 ; Amini M1
Authors

Source: Clinical Plasma Medicine Published:2018


Abstract

Purpose: In an in-vitro and in-vivo study, we investigated the effect of cold atmospheric pressure plasma jet (CAPPJ) in the treatment of Aspergillus fumigatus (A. fumigatus) keratitis. Methods: In the in vitro phase, suspensions of A. fumigatus with 106 colony forming units (CFUs) were exposed to CAPPJ, 1, 2, 3, 4, and 5 min per day for 7 consecutive days. After culturing the post-treatment suspension in Saboraud dextrose agar, fungal colonies were counted. The same experiment was performed for fungal colonies cultivated on agar plates. Mean logarithm of CFUs were compared between the baseline and CAPPJ-treated groups and also between the exposure times by using Friedman and Bonferroni tests. In the in vivo phase, 3 rabbits with A. fumigatus keratitis were treated with CAPPJ, 5 min daily for 3 days followed by microbiologic and histopathologic investigations on the excised corneas. Results: Agar plate and broth media treatment assays disclosed a significant decreasing rate in mean logarithm of CFUs with increased exposure time as compared to the baseline (P = 0.010 and P = 0.012, respectively). This decrease in both treatment assays was statistically significant in the 5 min-treatment group in comparison with the baseline (P = 0.016). However, in broth medium treatment assay, the decrease was slower and less than CAPPJ-treated agar plates. Direct application of the plasma jet in experimental model of rabbit A. fumigatus keratitis resulted in significant fungal inactivation evidenced by microbiologic and histopathologic investigations. Conclusion: Both in vitro and in vivo results demonstrated that CAPPJ treatment was effective in inactivating fungal pathogens and therefore it may be considered as a new treatment modality for fungal keratitis. However, further studies are required to investigate its long-term safety. © 2017 Elsevier GmbH
Other Related Docs
5. Clinical Features, Risk Factors, and Management of Candida Keratitis, Ocular Immunology and Inflammation (2023)
6. Fungal Keratitis Caused by Rare Organisms, Journal of Current Ophthalmology (2018)
9. Effects of Cosmetic Preservatives on Healthy Facial Skin Microflora, Journal of Clinical and Aesthetic Dermatology (2022)